HC Wainwright & Co. downgraded Bausch + Lomb from Buy to Neutral, while simultaneously increasing its price target from $21 to $22. This mixed analyst action indicates a revised outlook on the company's equity performance, suggesting a more cautious but still optimistic view on its valuation.
HC Wainwright & Co. downgraded Bausch + Lomb's stock rating from Buy to Neutral on November 2, 2026. This indicates a more cautious stance from the analyst firm regarding the company's short-term growth prospects or valuation. However, the simultaneous increase in the price target from $21 to $22 suggests that while the firm sees less immediate upside for a 'Buy' rating, they still believe the stock has room to grow from its previous target. This mixed signal could lead to short-term volatility for Bausch + Lomb shares, as investors weigh the downgrade against the higher price target. The long-term implications depend on whether the company can address the underlying reasons for the downgrade, potentially related to market conditions or company-specific performance. A key risk for traders is the potential for a negative market reaction to the downgrade, despite the raised price target.